Hagemann Jörn H, Berding Georg, Bergh Sven, Sleep Darryl J, Knapp Wolfram H, Jonas Udo, Stief Christian G
Department of Urology and Pediatric Urology, University School of Medicine, Carl-Neuberg-Strasse 1, D-30625, Hannover, Germany.
Eur Urol. 2003 Apr;43(4):412-20. doi: 10.1016/s0302-2838(03)00002-2.
The present study investigates whether cerebral activation during visually evoked sexual arousal is different in patients with erectile dysfunction (ED) compared to the known pattern observed in healthy men, and additionally how cerebral activity during visual sexual stimulation is modified by treatment with apomorphine SL and whether the observed cerebral activity correlates with penile rigidity.
Cerebral activity was measured before and after treatment in 12 patients with erectile dysfunction randomised to receive either apomorphine SL or placebo using [15O]H(2)O-PET. Two PET scans were performed prior to administration of the study medication, the first after a neutral audiovisual stimulus and the second following a sexually stimulating audiovisual presentation. After receiving the study medication, patients were subjected to two additional scans each preceded by a sexually stimulating stimulus. Penile rigidity was assessed with the RigiScan device. Evaluation for significant regional cerebral activation was performed using statistical parametric mapping (SPM99).
Cerebral activity increased significantly after the sexually stimulating video sequence compared to the neutral one in the inferior frontal cortex (Brodmann areas [BA] 47, 10, 11) and the rostral anterior cingulate (BA 32), and cerebral activity was observed to decrease in both inferior temporal cortices (BA 20). 4 out of 6 patients showed significant penile rigidity after apomorphine SL and in none of those receiving placebo. Apomorphine SL was observed to increase cerebral activity in the right superior prefrontal area (BA 6) that was not seen with placebo, while neither apomorphine SL nor placebo produced decreased cerebral activity. Penile rigidity correlated with increased cerebral activity in the anterior cingulum and right prefrontal cortex, and with decreased activity in the temporal cortex.
In patients with erectile dysfunction, the pattern of increased and decreased cerebral activity in response to visual sexual stimuli in this study is similar to that reported in the literature in healthy men. Apomorphine SL appears to induce additional cerebral activity in the right prefrontal cortex, an area previously shown to be associated with sexual arousal in male volunteers during orgasm. This increased cerebral activity was associated with penile rigidity, further supporting the conclusion that apomorphine SL improves erectile function in men with ED by enhancing the natural central erectile signals that normally occur during sexual stimulation.
本研究旨在调查勃起功能障碍(ED)患者在视觉诱发性唤起过程中的大脑激活情况与健康男性中观察到的已知模式是否不同,此外,阿扑吗啡口腔崩解片治疗如何改变视觉性刺激期间的大脑活动,以及观察到的大脑活动是否与阴茎硬度相关。
使用[15O]H₂O-PET对12例随机接受阿扑吗啡口腔崩解片或安慰剂治疗的勃起功能障碍患者在治疗前后进行大脑活动测量。在给予研究药物之前进行两次PET扫描,第一次在中性视听刺激后进行,第二次在性刺激视听呈现后进行。接受研究药物后,患者再接受两次额外的扫描,每次扫描前都有一次性刺激。使用RigiScan设备评估阴茎硬度。使用统计参数映射(SPM99)对显著的局部大脑激活进行评估。
与中性视频序列相比,在性刺激视频序列后,额下皮质(布罗德曼区[BA]47、10、11)和喙前扣带回(BA 32)的大脑活动显著增加,并且在双侧颞下皮质(BA 20)观察到大脑活动减少。6例患者中有4例在接受阿扑吗啡口腔崩解片治疗后出现显著的阴茎硬度,而接受安慰剂治疗的患者均未出现。观察到阿扑吗啡口腔崩解片可增加右侧额上前区(BA 6)的大脑活动,而安慰剂未观察到这种情况,同时阿扑吗啡口腔崩解片和安慰剂均未导致大脑活动减少。阴茎硬度与前扣带回和右侧前额叶皮质的大脑活动增加以及颞叶皮质的活动减少相关。
在勃起功能障碍患者中,本研究中对视觉性刺激作出反应的大脑活动增加和减少模式与文献中报道的健康男性相似。阿扑吗啡口腔崩解片似乎在右侧前额叶皮质诱导额外的大脑活动,该区域先前已被证明在男性志愿者性高潮期间与性唤起相关。这种大脑活动增加与阴茎硬度相关,进一步支持了阿扑吗啡口腔崩解片通过增强性刺激期间正常出现的自然中枢勃起信号来改善勃起功能障碍男性勃起功能的结论。